Hubbry Logo
PharmacistPharmacistMain
Open search
Pharmacist
Community hub
Pharmacist
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Pharmacist
Pharmacist
Pharmacist
View on Wikipedia
from Wikipedia

Pharmacist
A patient consulting a pharmacist
Occupation
NamesPharmacist, Chemist, Doctor of Pharmacy, Apothecary
Occupation type
Professional
Activity sectors
Health care, health sciences, chemical sciences
Description
CompetenciesMedication
Education required
Doctor of Pharmacy, Master of Pharmacy, Bachelor of Pharmacy
Fields of
employment
Pharmacy
Related jobs
Physician, pharmacy technician, toxicologist, chemist, other medical specialists

A pharmacist, also known as a chemist in Commonwealth English, is a healthcare professional who is knowledgeable about preparation, mechanism of action, clinical usage and legislation of medications in order to dispense them safely to the public and to provide consultancy services.[1][2] A pharmacist also often serves as a primary care provider in the community and offers services, such as health screenings and immunizations.

Pharmacists undergo university or graduate-level education to understand the biochemical mechanisms and actions of drugs, drug uses, therapeutic roles, side effects, potential drug interactions, and monitoring parameters. In developing countries, a diploma course from approved colleges qualifies one for pharmacist role. This is mated to anatomy, physiology, and pathophysiology. Pharmacists interpret and communicate this specialized knowledge to patients, physicians, and other health care providers.

Among other licensing requirements, different countries require pharmacists to hold either a Bachelor of Pharmacy, Master of Pharmacy, or a Doctor of Pharmacy degree.

The most common pharmacist positions are that of a community pharmacist (also referred to as a retail pharmacist, first-line pharmacist or dispensing chemist), or a hospital pharmacist, where they instruct and counsel on the proper use and adverse effects of medically prescribed drugs and medicines.[3][4] In most countries, the profession is subject to professional regulation. Depending on the legal scope of practice, pharmacists may contribute to prescribing (also referred to as "pharmacist prescribers") and administering certain medications (e.g., immunizations) in some jurisdictions. Pharmacists may also practice in a variety of other settings, including industry, wholesaling, research, academia, formulary management, military, and government.

Nature of work

[edit]
See also: Pharmacy

Historically, the fundamental role of pharmacists as a healthcare practitioner was to check and distribute drugs to doctors for medication that had been prescribed to patients. In more modern times, pharmacists advise patients and health care providers on the selection, dosages, interactions, and side effects of medications, and act as a learned intermediary between a prescriber and a patient. Pharmacists monitor the health and progress of patients to ensure the safe and effective use of medication. Pharmacists may practice compounding; however, many medicines are now produced by pharmaceutical companies in a standard dosage and drug delivery form. In some jurisdictions, pharmacists have prescriptive authority to either independently prescribe under their own authority or in collaboration with a primary care physician through an agreed upon protocol called a collaborative practice agreement.[5]

Increased numbers of drug therapies, aging but more knowledgeable and demanding populations, and deficiencies in other areas of the health care system seem to be driving increased demand for the clinical counseling skills of the pharmacist.[1] One of the most important roles that pharmacists are currently taking on is one of pharmaceutical care.[6] Pharmaceutical care involves taking direct responsibility for patients and their disease states, medications, and management of each to improve outcomes. Pharmaceutical care has many benefits that may include but are not limited to: decreased medication errors; increased patient compliance in medication regimen; better chronic disease state management, including hypertension and other cardiovascular disease risk factors;[7] strong pharmacist–patient relationship; and decreased long-term costs of medical care.

Pharmacists are often the first point-of-contact for patients with health inquiries. Thus pharmacists have a significant role in assessing medication management in patients, and in referring patients to physicians. These roles may include, but are not limited to:

  • clinical medication management, including reviewing and monitoring of medication regimens
  • assessment of patients with undiagnosed or diagnosed conditions, and ascertaining clinical medication management needs
  • specialized monitoring of disease states, such as dosing drugs in kidney and liver failure
  • compounding medicines
  • providing pharmaceutical information
  • providing patients with health monitoring and advice, including advice and treatment of common ailments and disease states
  • supervising pharmacy technicians and other staff
  • oversight of dispensing medicines on prescription
  • provision of and counseling about non-prescription or over-the-counter drugs
  • education and counseling for patients and other health care providers on optimal use of medicines (e.g., proper use, avoidance of overmedication)
  • referrals to other health professionals if necessary
  • pharmacokinetic evaluation
  • promoting public health by administering immunizations
  • constructing drug formularies
  • designing clinical trials for drug development
  • working with federal, state, or local regulatory agencies to develop safe drug policies
  • ensuring correctness of all medication labels including auxiliary labels
  • member of inter-professional care team for critical care patients[8]
  • symptom assessment leading to medication provision and lifestyle advice for community-based health concerns (e.g. head colds, or smoking cessation[9])
  • staged dosing supply (e.g. opioid substitution therapy[10])

Education and credentialing

[edit]
See also: Bachelor of Pharmacy, Master of Pharmacy, and Doctor of Pharmacy
Hospital Pharmacist
Hospital Pharmacist
Industrial Pharmacist
Industrial Pharmacist

The role of pharmacy education, pharmacist licensing, and continuing education vary from country to country and between regions/localities within countries. In most countries, pharmacists must obtain a university degree at a pharmacy school or related institution, and/or satisfy other national/local credentialing requirements. In many contexts, students must first complete pre-professional (undergraduate) coursework, followed by about four years of professional academic studies to obtain a degree in pharmacy (such as Doctorate of Pharmacy). In the European Union, pharmacists are required to hold a Masters of Pharmacy, which allows them to practice in any other E.U. country, pending professional examinations and language tests in the country in which they want to practice. Pharmacists are educated in pharmacology, pharmacognosy, chemistry, organic chemistry, biochemistry, pharmaceutical chemistry, microbiology, pharmacy practice (including drug interactions, medicine monitoring, medication management), pharmaceutics, pharmacy law, pathophysiology, physiology, anatomy, drug delivery, pharmaceutical care, nephrology, hepatology, and compounding of medications. Additional curriculum may cover diagnosis with emphasis on laboratory tests, disease state management, therapeutics and prescribing (selecting the most appropriate medication for a given patient).

Upon graduation, pharmacists are licensed, either nationally or regionally, to dispense medication of various types in the areas they have trained for.

Some may undergo further specialized training, such as in cardiology or oncology or long-term care. Specialties include:[citation needed]

Training and practice by country

[edit]

Armenia

[edit]

The Ministry of Education and Ministry of Health oversee pharmacy school accreditation in Armenia. Pharmacists are expected to have competency in the WHO Model List of Essential Medicines (EML), the use of Standard Treatment Guidelines, drug information, clinical pharmacy, and medicine supply management. There are currently no laws requiring pharmacists to be registered, but all pharmacies must have a license to conduct business. According to a World Health Organization (WHO) report from 2010, there are 0.53 licensed pharmacists and 7.82 licensed pharmacies per 10,000 people in Armenia. Pharmacists are able to substitute for generic equivalents at point of dispensing.[11]

Australia

[edit]
See also: Australian Pharmaceutical Advisory Council

The Australian Pharmacy Council is the independent accreditation agency for Australian pharmacists.[12] The accreditation standards for Australian pharmacy degrees include compulsory clinical placements.[13] with an emphasis on encouraging rural experiences to develop a rural workforce.[14][15] It conducts a written examination on behalf of the Pharmacy Board of Australia towards eligibility for registration. The Pharmacy Board of Australia conducts an oral examination at the end of the intern year as the last hurdle prior to registration. The Pharmaceutical Society of Australia provides continuing education programs for pharmacists. The number of full-time equivalent pharmacists working in Australia over the past decade has remained stable.[16] Pharmacy practice is described by the practice standards [17] and guidelines including those from the Pharmaceutical Society of Australia.[18][19][20][21]

The Australian Pharmacy Council is developing accreditation standards for pharmacists to prescribe and for pharmacists to work in aged care. The aged care accreditation standards are being developed in preparation for pharmacists working in residential aged care settings to ensure that they are adequately prepared.[22]

There is a shortage of pharmacists at present leaving many jobs unfilled.[citation needed] Despite many pharmacists leaving the profession, pharmacists remain optimistic about their profession.[23] Contract and casual work is becoming more common. A contract pharmacist is self-employed and often called a locum; these pharmacists may be hired for one shift or for a longer period of time. The number of pharmacists has stayed stable over a number of years.[16]

Canada

[edit]

The Canadian Pharmacists Association (CPhA) is the national professional organization for pharmacists in Canada. Specific requirements for practice vary across provinces, but generally include a bachelor's (BSc Pharm) or Doctor of Pharmacy (PharmD) degree from one of 10 Canadian universities offering a pharmacy program, successful completion of a national board examination through the Pharmacy Examining Board of Canada (PEBC) (Quebec being the exception), practical experience through an apprenticeship/internship program, and fluency in French or English.[24] International pharmacy graduates can begin their journey of becoming licensed to practice in Canada by enrolling with the National Association of Pharmacy Regulatory Authorities (NAPRA) Pharmacists' Gateway Canada.[24][25] The vast majority (~70%) of Canada's licensed pharmacists work in community pharmacies, another 15% work in hospital, and the remainder work in other settings such as industry, government, or universities.[26][27][28] Pharmacists' scope of practice varies widely among the 13 provinces and territories and continues to evolve with time.[29][30] As a result of pharmacists' expanding scope and knowledge application, there has been a purposeful effort to transition the professional programs in Canadian pharmacy schools to offer doctors of pharmacy over baccalaureate curriculums to ensure graduates have the most up to date level of training to match the increasing practice requirements.[31][32]

European Union

[edit]

The pharmacist qualification in the European Union is regulated by the Directive 2005/36/EC,[33] where Section 7 Article 44(2) mandates at least five years of training including "four years of full-time theoretical and practical training" and "six-month traineeship in a pharmacy which is open to the public or in a hospital, under the supervision of that hospital's pharmaceutical department". The training of pharmacist must include at least: "Plant and animal biology, Physics, General and inorganic chemistry, Organic chemistry, Analytical chemistry, Pharmaceutical chemistry, including analysis of medicinal products, General and applied biochemistry (medical), Anatomy and physiology; medical terminology, Microbiology, Pharmacology and pharmacotherapy, Pharmaceutical technology, Toxicology, Pharmacognosy, Legislation and, where appropriate, professional ethics", which can be adapted to "scientific and technical progress" according to procedure in Directive 2005/36/EC.[33]

Germany

[edit]

In Germany, the education and training is divided into three sections, each ending with a state examination:

  • University: Basic studies (at least four semesters)
  • University: Main studies (at least four semesters)
  • Community Pharmacy / Hospital Pharmacy / Industry: Practical training (12 months; 6 months in a Community Pharmacy).

After the third state examination a person must become licensed as an RPh ("registered pharmacist") for a licence to practice pharmacy. Today, many pharmacists work as employees in public pharmacies.

Poland

[edit]

Polish pharmacists have to complete a 5+1⁄2-year Master of Pharmacy Programme at medical university and obtain the right to practice as a pharmacist in Poland from District Pharmaceutical Council. The Programme includes six months of pharmacy training. The Polish name for the Master of Pharmacy Degree (M.Pharm.) is magister farmacji (mgr farm). Not only pharmacists, but also pharmaceutical technicians are allowed to dispense prescription medicines, except for narcotics, psychotropics and very potent medicines. Pharmacists approve prescriptions fulfilled by pharmaceutical technicians subsequently. Pharmaceutical technicians have to complete two years of post-secondary occupational school and 2 years of pharmacy training afterwards. Pharmacists are eligible to prescribe medicines in exceptional circumstances. All Polish pharmacies are obliged to produce compound medicines. Most pharmacists in Poland are pharmacy managers and are responsible for pharmacy marketing in addition to traditional activities. To become a pharmacy manager in Poland, a pharmacist is expected to have at least five years of professional experience. All pharmacists in Poland have to maintain an adequate knowledge level by participating in various university- and industry-based courses and arrangements or by undergoing postgraduate specialization.[34]

Sweden

[edit]

In Sweden, the national board of health and welfare regulates the practice of all legislated health care professionals, and is also responsible for registration of pharmacists in the country. The education to become a licensed pharmacist is regulated by the European Union, and states that minimum educational requirements are five years of university studies in a pharmacy program, of which six months must be a pharmacy internship. To be admitted to pharmacy studies, students must complete a minimum of three years of gymnasium, similar to high school (school for about 15–20-year-old students) program in natural science after elementary school (6–16-year-olds). Only three universities in the whole of Sweden offer a pharmacy education, Uppsala University, where the Faculty of Pharmacy is located, the University of Gothenburg, and Umeå University. In Sweden, pharmacists are called Apotekare. At pharmacies in Sweden, pharmacists work together with another class of legislated health care professionals called Receptarier, in English so-called prescriptionists, who have completed studies equal to a Bachelor of Science in pharmacy, i.e., three years of university. Prescriptionists also have dispensing rights in Sweden, Norway, Finland and Iceland. The majority of the staff in a pharmacy are Apotekstekniker or "pharmacy technicians" with a three -semester education at a vocational college.[citation needed] Pharmacy technicians do not have dispensing rights in Sweden but are allowed to advise on and sell over-the-counter medicines.

Japan

[edit]

History

[edit]

In ancient Japan, the men who fulfilled roles similar to pharmacists were respected. The place of pharmacists in society was settled in the Taihō Code (701) and re-stated in the Yōrō Code (718). Ranked positions in the pre-Heian Imperial court were established; and this organizational structure remained largely intact until the Meiji Restoration (1868). In this highly stable hierarchy, the pharmacists — and even pharmacist assistants — were assigned status superior to all others in health-related fields such as physicians and acupuncturists. In the Imperial household, the pharmacist was even ranked above the two personal physicians of the Emperor.[35]

Contemporary

[edit]

As of 1997, 46 universities of pharmacy in Japan graduated about 8000 students annually.[36] Contemporary practice of clinical pharmacists in Japan (as evaluated in September 2000) focuses on dispensing of drugs, consultation with patients, supplying drug information, advising on prescription changes and amending prescriptions. These practices have been linked to decreases in the average number of drugs in prescriptions, drug costs and incidence of adverse drug events.[37]

Nigeria

[edit]

Training to become a registered pharmacist in Nigeria involves a five-year course after six years of secondary/high school or four years after eight years of secondary/high school (i.e. after 2 years of Advanced-level studies in accredited Universities). The degree awarded by most pharmacy schools is a Bachelor of Pharmacy Degree (B.Pharm.) However, in the near future,[when?] all schools will offer a 6-year first Degree course leading to the award of a Pharm.D (Doctor of Pharmacy Degree). The University of Benin has started the Pharm.D programme with other pharmacy schools planning to start soon. The Pharmacy Degree in Nigeria is unclassified i.e. awarded without first class, second class upper, etc., however graduates could be awarded Pass with Distinctions in specific fields such as Pharmaceutics, Pharmacology, medicinal chemistry etc. Pharmacy Graduates are required to undergo 1 year of Tutelage under the supervision of an already Registered Pharmacist(a preceptor) in a recognized and designated Institution before they can become Registered Pharmacists. The Profession is Regulated by a Government Statutory body called the Pharmacists Council of Nigeria. The West African Post Graduate College of Pharmacy runs post-registration courses on advanced-level practice in various fields of pharmacy. It is a college jointly funded by a number of Countries in the West Africa sub-region.

Pakistan

[edit]

In Pakistan, the Pharm.D. (Doctor of Pharmacy) degree is a graduate-level professional doctorate degree. Twenty-one universities are registered with the Pharmacy Council of Pakistan for imparting Pharmacy courses. In 2004 the Higher Education Commission of Pakistan and the Pharmacy Council of Pakistan revised the syllabus and changed the 4-year B.Pharmacy (Bachelor of Pharmacy) Program to a 5-year Pharm.D. (Doctor of Pharmacy) program. All 21 universities have started the 5-year Pharm.D Program. In 2011 the Pharmacy Council of Pakistan approved the awarding of a Doctor of Pharmacy degree, a five-year programme at the Department of Pharmacy, University of Peshawar.[citation needed]

Switzerland

[edit]

In Switzerland, the federal office of public health regulates pharmacy practice. Four Swiss universities offer a major in pharmaceutical studies, the University of Basel, the University of Geneva, the University of Lausanne and the ETH Zurich. To major in pharmaceutical studies takes at least five years. Students spend their last year as interns in a pharmacy combined with courses at the university, with focus on the validation of prescriptions and the manufacturing of pharmaceutical formulations. Since all public health professions are regulated by the government it is also necessary to acquire a federal diploma in order to work in a pharmacy. It is not unusual for pharmaceutical studies majors to work in other fields such as the pharmaceutical industry or in hospitals. Pharmacists work alongside pharma assistants, an apprenticeship that takes three years to complete. Pharmacists can further specialize in various fields; this is organized by PharmaSuisse, the pharmacists' association of Switzerland.[citation needed]

Tanzania

[edit]

In Tanzania, pharmacy practice is regulated by the national Pharmacy Board, which is also responsible for registration of pharmacists in the country. By international standards, the density of pharmacists is very low, with a mean of 0.18 per 10,000 population. The majority of pharmacists are found in urban areas, with some underserved regions having only 2 pharmacists per region. According to 2007–2009 data, the largest group of pharmacists was employed in the public sector (44%). Those working in private retail pharmacies were 23%, and the rest were mostly working for private wholesalers, pharmaceutical manufacturers, in academia/teaching, or with faith-based or non-governmental facilities. The salaries of pharmacists varied significantly depending on the place of work. Those who worked in the academia were the highest paid followed by those who worked in the multilateral non-governmental organizations. The public sector including public retail pharmacies and faith based organizations paid much less. The Ministry of Health salary scale for medical doctors was considerably higher than that of pharmacists despite having a difference of only one year of training.[38]

Trinidad and Tobago

[edit]

In Trinidad and Tobago, pharmacy practice is regulated by the Pharmacy Board of Trinidad and Tobago, which is responsible for the registration of pharmacists in the twin islands. The University of the West Indies in St. Augustine offers a 4-year Bachelor of Science in Pharmacy as the sole practicing degree of pharmacy. Graduates undertake a 6-month internship, known as pre-registration, under the supervision of a registered pharmacist, at a pharmacy of their choosing, whether community or institutional. After completion of the required pre-registration period, the graduate can then apply to the Pharmacy Board to become a registered pharmacist. After working 1 calendar year as a registered pharmacist, the individual can become a registered, responsible pharmacist. Being a registered, responsible pharmacist allows the individual to license a pharmacy and be a pharmacist-in-charge.

United Kingdom

[edit]
See also: Consultant pharmacist

In British English (and to some extent Australian English), the professional title known as "pharmacist" is also known as "dispensing chemist" or, more commonly, "chemist". A dispensing chemist usually operates from a pharmacy or chemist's shop, and is allowed to fulfil medical prescriptions and sell over-the-counter drugs and other health-related goods. Pharmacists can undertake additional training to allow them to prescribe medicines for specific conditions.[39]

Practices

[edit]

In the United Kingdom, most pharmacists working in the National Health Service practice in hospital pharmacy or community pharmacy. The Royal Commission on the National Health Service in 1979 reported that there were nearly 3,000 pharmacists employed in the hospital and community health service in the UK at that time. They were enthusiastic about the idea that pharmacists might develop their role of giving advice to the public.[40]

The new professional role for pharmacist as prescriber has been recognized in the UK since May 2006, called the "Pharmacist Independent Prescriber". Once qualified, a pharmacist independent prescriber can prescribe any licensed medicine for any medical condition within their competence. This includes controlled drugs except schedule 1 and prescribing certain drugs for the treatment of addiction (cocaine, diamorphine and dipipanone).[41]

Education and registration

[edit]

Pharmacists, pharmacy technicians and pharmacy premises in the United Kingdom are regulated by the General Pharmaceutical Council (GPhC) for England, Scotland and Wales and by the Pharmaceutical Society of Northern Ireland for Northern Ireland. The role of regulatory and professional body on the mainland was previously carried out by the Royal Pharmaceutical Society of Great Britain, which remained as a professional body after handing over the regulatory role to the GPhC in 2010.[42]

The following criteria must be met for qualification as a pharmacist in the United Kingdom (the Northern Irish body and the GPhC operate separately but have broadly similar registration requirements):[43]

  • Successful completion of a 4-year Master of Pharmacy degree at a GPhC accredited university. Pharmacists holding degrees in pharmacy from overseas institutions are able to fulfill this stage by undertaking the Overseas Pharmacist Assessment Programme (OSPAP), which is a one-year postgraduate diploma. On completion of the OSPAP, the candidate would proceed with the other stages of the registration process in the same manner as a UK student.
  • Completion of a 52-week preregistration training period. This is a period of paid or unpaid employment, in an approved hospital or community pharmacy under the supervision of a pharmacist tutor. During this time the student must collect evidence of having met certain competency standards set by the GPhC.
  • A pass mark in the GPhC registration assessment (formally an exam). This includes a closed-book paper and an open-book/mental calculations paper (using the British National Formulary and the GPhC's "Standards of Conduct, Ethics and Performance" document as reference sources). The student must achieve an overall mark of 70%, which must include at least 70% in the calculations section of the open-book paper. From June 2016, the assessment will involve two papers, as before but the use of a calculator will now be allowed. However, reference sources will no longer be allowed in the assessment. Instead, relevant extracts of the British National Formulary will be provided within the assessment paper.
  • Satisfactorily meeting the GPhC's Fitness to Practice Standards.

United States

[edit]

In 2014, the United States Bureau of Labor Statistics revealed that there were 297,100 American pharmacist jobs. By 2024 that number was projected to grow by 3%.[44][needs update] The majority (65%) of those pharmacists work in retail settings, mostly as salaried employees but some as self-employed owners. About 22% work in hospitals, and the rest mainly in mail-order or Internet pharmacies, pharmaceutical wholesalers, practices of physicians, and the Federal Government.[4]

All graduating pharmacists must now obtain the Doctor of Pharmacy (Pharm.D.) degree before they are eligible to sit for the North American Pharmacist Licensure Examination (NAPLEX) to enter into pharmacy practice.[45] In addition, pharmacists are subject to state-level jurisprudence exams in order to practice from state to state.[46]

Pharmacy School Accreditation

[edit]

The Accreditation Council for Pharmacy Education (ACPE) has operated since 1932 as the accrediting body for schools of pharmacy in the United States.[47] The mission of ACPE is "To assure and advance excellence in education for the profession of pharmacy".[47] ACPE is recognized for the accreditation of professional degree programs by the United States Department of Education (USDE) and the Council for Higher Education Accreditation (CHEA).[48] Since 1975, ACPE has also been the accrediting body for continuing pharmacy education. The ACPE board of directors are appointed by the American Association of Colleges of Pharmacy (AACP), the American Pharmacists Association (APhA), the National Association of Boards of Pharmacy (NABP) (three appointments each), and the American Council on Education (one appointment). To obtain licensure in the United States, applicants for the North American Pharmacist Licensure Examination (NAPLEX) must graduate from an ACPE accredited school of pharmacy. ACPE publishes standards that schools of pharmacy must comply with to gain accreditation.[49]

A Pharmacy school pursuing accreditation must first apply and be granted Pre-candidate status.[48] These schools have met all the requirements for accreditation, but have not yet enrolled any students. This status indicates that the school of pharmacy has developed its program in accordance with the ACPE standards and guidelines. Once a school has enrolled students, but has not yet had a graduating class, they may be granted Candidate status. The expectations of a Candidate program are that they continue to mature in accordance with stated plans. The graduates of a Candidate program are the same as those of fully accredited programs. Full accreditation is granted to a program once they have demonstrated they comply with the standards set forth by ACPE.

The customary review cycle for established accredited programs is six years, whereas for programs achieving their initial accreditation this cycle is two years. These are comprehensive on-site evaluations of the programs. Additional evaluations may be conducted at the discretion of ACPE in the interim between comprehensive evaluations.

Education

[edit]

Acceptance into a doctorate of pharmacy program depends upon completing specific prerequisites or obtaining a transferable bachelor's degree. Pharmacy school is four years of graduate school (accelerated Pharmacy Schools go January to January and are only three years), which include at least one year of practical experience. Graduates receive a Doctorate of Pharmacy (PharmD) upon graduation. Most schools require students to take a Pharmacy College Admissions Test PCAT and complete 90 credit hours of university coursework in the sciences, mathematics, composition, and humanities before entry into the PharmD program. Due to the large admittance requirements and highly competitive nature of the field, most pharmacy students complete a bachelor's degree before entry to pharmacy school.

Possible prerequisites:

Besides taking classes, additional requirements before graduating may include a certain number of hours for community service, e.g., working in hospitals, clinics, and retail.

Estimated timeline: 4 years undergraduate + 4 years doctorate + 1–2 years residency + 1–3 years fellowship = 8–13 years

A doctorate of pharmacy (except non-traditional, i.e. transferring a license from another country) is the only degree accepted by the National Associate of Boards of Pharmacy NABP to be eligible to "sit" for the North American Pharmacist Licensure Examination (NAPLEX). Previously the United States had a 5-year bachelor's degree in pharmacy. For BS Pharmacy graduates currently licensed in US, there are 10 Universities offering non-traditional doctorate degree programs via part-time, weekend or on-line programs. These are programs fully accredited by Accreditation Council for Pharmacy Education (ACPE) but only available to current BS Pharmacy graduates with a license to practice pharmacy. Some institutions still offer 6 year accelerated PharmD programs.

The current Pharm.D. degree curriculum is considerably different from that of the prior BS in pharmacy. It now includes extensive didactic clinical preparation, a full year of hands-on practice experience in a wider array of healthcare settings, and a greater emphasis on clinical pharmacy practice pertaining to pharmacotherapy optimization. Legal requirements in the US to becoming a pharmacist include: graduating from an accredited PharmD program, conducting a specified number of internship hours under a licensed pharmacist (i.e. 1800 hours in some states), passing the NAPLEX, and passing a Multi-state Pharmacy Jurisprudence Exam MPJE. Arkansas, California, and Virginia have their own exams instead of the MPJE; in those states, pharmacists must pass the Arkansas Jurisprudence Exam, the California Jurisprudence Exam, or the Virginia Pharmacy Law Exam.[50][51][52]

Residency is an option for post-graduates that is typically 1–2 years in length. A residency gives licensed pharmacists decades of clinical experience in an extremely condensed timeframe of only a few short years. In order for new graduates to remain competitive, employers generally favor residency trained applicants for clinical positions. The profession is moving toward resident-trained pharmacists who wish to provide direct patient care clinical services. In 1990, the American Association of Colleges of Pharmacy (AACP) required the new professional degree. Graduates from a PharmD program may also elect to do a fellowship that is geared toward research. Fellowships can varying in length but last 1–3 years depending on the program and usually require 1 year of residency at minimum.

Specialization and credentialing

[edit]
Clinical pharmacists go on rounds with doctors in order to provide direct patient care and comprehensive medication management.

American pharmacists can become certified in recognized specialty practice areas by passing an examination administered by one of several credentialing boards.

Expanding scope of practice

[edit]
Vaccinations
[edit]

As of 2016, all 50 states and the District of Columbia permit pharmacists to provide vaccination services, but specific protocols vary between states.[56][57][58]

California
[edit]

All licensed California pharmacists can perform the following:

  • Order and interpret drug therapy related tests
  • Furnish smoking cessation aids (such as nicotine replacement therapy)
  • Furnish oral self-administered contraception (birth control pills)
  • Furnish travel medications recommended by the CDC[59]
  • Administer vaccinations pursuant to the latest CDC standards for anyone ages 3+[60]

The passage of Assembly Bill 1535 (2014) authorizes pharmacists in California to furnish naloxone without a physician's prescription.[61]

With the passage of Senate Bill 159 in 2019, pharmacists in California are authorized to furnish pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to patients without a physician's prescription.[62] In order to be eligible to dispense, a pharmacists must first "complete a training program approved by the" California State Board of Pharmacy.[62]

California pharmacists can apply for Advanced Practice Pharmacist (APh) licenses from the California State Board of Pharmacy. Senate Bill 493, written by Senator Ed Hernandez, established a section on the Advanced Practice Pharmacist and outlines the definition, scope of practice, qualifications, and regulations of those holding this license.[63] An APh can:

  • Perform patient assessments
  • Refer patients to other healthcare providers
  • Participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers
  • Initiate, adjust, or discontinue therapy pursuant to the regulations outlined in the bill[63]

To qualify for an advanced practice pharmacist license in California, the applicant must be in good standing with the State Board of pharmacy, have an active pharmacist license, and fulfill two of three requirements, including certification in their area clinical practice.[64] The license must be renewed every 2 years, and the APh applying for renewal must complete 10 hours of continuing education in at least one area relevant to their clinical practice.[64]

Earnings and wages

[edit]

According to a 2010 PharmacyWeek survey, pharmacists were paid the following average annual salaries, depending on their positions:[65]

  • Directors of Pharmacy $125,200
  • Retail Staff Pharmacists $113,600
  • Hospital Staff Pharmacists $111,700
  • Mail Order Staff Pharmacists $109,300
  • Clinical Pharmacists $113,400

The American Pharmacy Journal of Education in 2014 reported the average salary around $112,160.[66]

According to the US Bureau of Labor Statistics' Occupational Outlook Handbook, 2016–17 Edition, Median annual wages of wage and salary pharmacists in May 2015 were $121,500.[44]

In 2020 US News and World Report noted that the median pharmacist salary was $128,710. The top 25 percent of pharmacist earners made $147,690 that year, while the lowest 25 percent made $112,690.[67]

Vietnam

[edit]

School students must take a national exam to enter a university of pharmacy or the pharmacy department of a university of medicine and pharmacy. About 5–7% of students can pass the exam. There are 3 aspects to the exam. These are on math, chemistry, and physics or biology. After being trained at the university for 5 years, successful students receive a bachelor's degree in pharmacy. Or they are university pharmacists (university pharmacist to discriminate between college pharmacist or vocational pharmacist in some countries of the world these trainee pharmacists are called pharmacist assistants). An alternative method of obtaining a bachelor's degree is as follows. School pupils study at a college of pharmacy or a vocational school of pharmacy. After attending the school or college they go to work in a pharmacy, and with two years of practice they could take an exam to enter university of pharmacy or the pharmacy department of a university of medicine and pharmacy. This exam is easier than the national one. Passing the exam they continue studying to gain 3-year bachelor's degrees or 4-year bachelor's degrees. This degree is considered equivalent to a 5-year bachelor's degree.[citation needed]

Notable pharmacists

[edit]
Main article: List of pharmacists

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Pharmacist

View on Grokipedia
from Grokipedia
A pharmacist is a licensed healthcare who dispenses prescription medications to patients and provides on their safe and effective use, while also advising physicians and other providers on to optimize patient outcomes. Pharmacists play a critical role in , ensuring appropriate dosing, monitoring for adverse effects, and promoting adherence to treatment plans, which helps prevent medication errors and improves overall . In addition to traditional dispensing duties, modern pharmacists engage in expanded responsibilities such as conducting health screenings, administering vaccinations, performing , and managing chronic diseases through collaborative practice agreements with other healthcare providers. They work in diverse settings, including community pharmacies, hospitals, clinics, and facilities, often collaborating with interdisciplinary teams to integrate medication therapy into comprehensive patient care. There are several types of pharmacists, each with specialized roles: community pharmacists primarily fill prescriptions and counsel in retail settings like drug stores and grocery stores; hospital pharmacists oversee medication distribution, prepare sterile compounds, and provide clinical consultations within environments; and other specialties include clinical pharmacists who focus on direct care in settings, as well as roles in , industry, and research. To enter the profession, pharmacists must complete a (Pharm.D.) degree from an accredited program, which typically takes four years after undergraduate prerequisites, followed by passing licensure exams in all U.S. states and completing internships or residencies for advanced practice. The field is projected to grow by 5% from 2024 to 2034, driven by an aging population and increasing demand for medication management services, with about 335,100 jobs in the U.S. as of 2024 and a annual of $137,480. Globally, pharmacists are recognized as essential to health systems, with evolving roles in disease prevention and , as highlighted by initiatives like World Pharmacists Day.

Role and Responsibilities

Core Duties

Pharmacists are primarily responsible for the accurate dispensing of prescription medications, which involves reviewing prescriptions from healthcare providers to verify the appropriateness of the , dosage, and instructions for use. This includes checking for potential drug interactions, allergies, and contraindications to ensure before preparing and labeling the medication for distribution. Pharmacists exercise judgment to identify errors or issues in prescriptions and may contact prescribers for clarification, adhering to federal regulations such as those outlined by the for controlled substances. In cases where commercially available medications do not meet needs, pharmacists perform , the process of mixing or altering ingredients to create customized formulations. is divided into non-sterile preparations, such as creams, ointments, or oral liquids for topical or internal use, and sterile preparations, like injectables or intravenous solutions that require a controlled environment to prevent . These activities must comply with standards from the U.S. Pharmacopeia and FDA guidelines to ensure quality and safety, particularly for sterile which demands specialized facilities and training to avoid risks like microbial . Pharmacists manage pharmaceutical to maintain adequate while minimizing and ensuring compliance with storage and disposal requirements. This includes ordering medications from suppliers, monitoring expiration dates, and implementing systems to track usage and prevent shortages or overstocking. Proper storage conditions, such as for sensitive drugs, and safe disposal methods for expired or unused pharmaceuticals—often following EPA and state regulations—are essential to protect and the environment. Administrative responsibilities encompass maintaining accurate patient records, which document medication histories, dispensing details, and any interventions, to support continuity of care and legal compliance. Pharmacists also process insurance claims, verifying coverage, submitting reimbursements, and resolving billing issues to facilitate access to medications. In practice, these duties extend to recommending over-the-counter (OTC) medications, where pharmacists assess patient symptoms and suggest appropriate products, such as analgesics or antacids, while advising on safe usage to avoid interactions with prescription drugs. During medication shortages, pharmacists play a critical role in sourcing alternatives, prioritizing supplies, and communicating with healthcare teams to mitigate disruptions in care.

Scope of Practice

The for pharmacists refers to the legal and professional boundaries that define the procedures, actions, and processes they are permitted to perform within their , including activities such as prescribing medications, administering vaccines, and conducting . These permissions vary significantly by country and, in federal systems like the , by state, often governed by statutes, regulations, and professional standards that ensure and integration with other healthcare providers. For instance, in many regions, pharmacists are authorized to administer immunizations to individuals above a certain age, such as five years old in some U.S. states, reflecting adaptations to needs. , which involves on-site diagnostic assessments like rapid tests for infections, is increasingly included in scopes of practice, though explicit legislation remains limited in some areas. Historically, the pharmacist's role evolved from a focus on medications in the early to a more patient-centered orientation by the mid- to late , driven by advancements in and recognition of pharmacists' expertise in drug . As mass-produced drugs reduced the need for manual , pharmacists shifted toward dispensing and, from the 1950s onward, toward clinical responsibilities like monitoring outcomes, culminating in the 1970s concept of "" that emphasized optimizing patient health through medication management. This transition was supported by educational reforms and policy changes that positioned pharmacists as integral to the healthcare team. Key expansions in scope have included pharmacist-led medication therapy management (MTM), which involves comprehensive reviews of a patient's medications to improve adherence and outcomes, often reimbursed under programs like in the U.S. Collaborative practice agreements (CPAs) with physicians enable pharmacists to adjust therapies, order tests, or initiate treatments for chronic conditions, enhancing team-based care in settings like community pharmacies. Additionally, authority for prescribing treatments for minor ailments—such as urinary tract infections or allergic reactions—has been granted in select regions, allowing pharmacists to manage low-risk conditions independently. , all 50 states and the District of Columbia grant pharmacists some form of prescriptive authority, typically for specific medications such as or contraceptives through collaborative practice agreements (CPAs) or protocols; the number of states varies by medication type (e.g., 30 states and DC for contraceptives as of 2025). Globally, the has allowed independent pharmacist prescribing since 2006, enabling qualified pharmacists to prescribe any medicine for any condition within their competence. Despite these advancements, barriers to further expansion persist, including legislative hurdles where proposed bills face opposition from medical associations concerned about and care coordination. Interprofessional tensions, such as resistance from physicians over perceived encroachment on diagnostic roles, can hinder trust-building and implementation of collaborative models. Other challenges include reimbursement limitations and varying state requirements for training, which slow the adoption of expanded services.

Patient Interaction and Counseling

Pharmacists interact with patients to promote safe and effective use by providing personalized on treatment plans. This counseling process typically includes explaining the 's purpose, potential side effects, proper administration techniques, and strategies to enhance adherence, such as reminder systems or lifestyle integrations. According to guidelines from the (ASHP), effective counseling begins with establishing a trusting relationship, assessing the patient's knowledge and needs, delivering clear information tailored to their , and confirming comprehension through interactive . In many countries, verbal counseling is mandated for new prescriptions to ensure patients receive essential guidance. For instance, in the United States, the Omnibus Budget Reconciliation Act of 1990 (OBRA '90) requires pharmacists to offer counseling to recipients on new medications, covering aspects like dosage, interactions, and storage. Globally, the Joint FIP/WHO Guidelines on Good Pharmacy Practice emphasize that pharmacists must provide patient-centered counseling, acknowledging factors such as cultural beliefs, literacy levels, and native languages to optimize outcomes. To facilitate understanding, pharmacists employ evidence-based tools and methods during interactions. The teach-back method, where patients restate instructions in their own words, is widely recommended to verify comprehension and address misunderstandings, thereby improving adherence and reducing errors. Multilingual resources, including translated leaflets and interpretation services, support diverse populations, while digital apps enable ongoing education through interactive reminders, videos, and adherence tracking features. Counseling is particularly tailored for special populations to address unique needs. In , pharmacists focus on age-appropriate dosing, flavoring options, and involvement to ensure safe administration. For , emphasis is placed on simplifying regimens to mitigate risks, monitoring for age-related sensitivities, and promoting with certain medications. Patients with chronic conditions, such as or , receive targeted guidance on integrating medications with diet, exercise, and self-monitoring to achieve better glycemic or control. During transitions of care, such as hospital discharge, pharmacists contribute to medication by reviewing and resolving discrepancies in medication lists, educating patients on changes, and coordinating with providers to prevent errors. This role is critical, as pharmacists' involvement in reconciliation processes has been shown to identify and correct a significant number of potential issues that could lead to harm. Studies demonstrate that pharmacist-led counseling significantly reduces preventable adverse drug events, with one randomized trial reporting a 90% relative reduction in such incidents 30 days post-hospitalization through medication review, counseling, and follow-up. Overall, these interventions can lower adverse event rates in high-risk settings by enhancing patient knowledge and adherence.

Education and Training

Academic Programs

Academic programs in pharmacy typically culminate in the (PharmD) degree, which serves as the entry-level professional qualification in many countries, including the . These programs generally span 4 to 6 years following high school completion, often comprising 2 years of prerequisite undergraduate coursework followed by 4 years of professional study, though some integrated models exist. In the U.S., the transition to the PharmD as the sole entry-level degree occurred in 2000, phasing out the previous (BPharm) to emphasize advanced clinical training. In , integrated programs combining bachelor's and master's levels are common, such as the 5-year (MPharm) degrees offered in countries like the , , and , aligning with directives for pharmacist education. Admission to PharmD programs requires completion of prerequisite courses in the sciences, typically including (with labs), , , and , , statistics, and English composition, with a minimum cumulative GPA of around 2.75 to 3.0 often expected. Many programs mandate letters of recommendation, personal statements, and interviews, while the Pharmacy College Admission Test (PCAT) is required by some institutions, though its use has declined in recent years as holistic admissions gain prominence. International applicants may need to demonstrate English proficiency and equivalency of prior . The core curriculum of PharmD programs integrates foundational with pharmacy-specific disciplines to prepare students for clinical decision-making and patient care. Key subjects include , which covers drug mechanisms and effects; , focusing on drug formulation and delivery systems; , exploring and synthesis; and , which quantifies drug absorption, distribution, , and elimination in the body. Students also study , , , and pharmacy law and ethics to understand regulatory frameworks and . education introduces fundamental equations, such as the elimination calculation: t1/2=0.693kelt_{1/2} = \frac{0.693}{k_{el}} where t1/2t_{1/2} is the half-life and kelk_{el} is the elimination rate constant, enabling predictions of drug dosing intervals and therapeutic monitoring. This curriculum evolves through didactic lectures, laboratories, and problem-based learning to foster evidence-based practice. Experiential learning forms a cornerstone of pharmacy education, bridging classroom theory with real-world application through Introductory Pharmacy Practice Experiences (IPPEs) and Advanced Pharmacy Practice Experiences (APPEs). IPPEs, typically occurring in the first three professional years, provide early exposure to , institutional, and settings, totaling at least 300 hours as mandated by standards. APPEs, conducted in the final year, involve immersive rotations in diverse areas like , , and specialty pharmacy, requiring a minimum of 1,440 hours, with each rotation lasting at least 160 hours. Overall, these experiences accumulate 1,000 to 2,000 hours, emphasizing skills in counseling, medication therapy management, and interprofessional collaboration, and are accredited by bodies like the Accreditation Council for Pharmacy Education (ACPE) to ensure competency.

Licensure and Certification

In the United States and , licensure as a pharmacist requires passing the North American Pharmacist Licensure Examination (NAPLEX), which assesses a candidate's competency in practice, including safe and effective provision of patient care. Administered by the National Association of Boards of Pharmacy (NABP), the NAPLEX consists of 225 multiple-choice questions over 6 hours, covering areas such as evaluating and managing drug therapy. First-time pass rates for graduates of Accreditation Council for Pharmacy Education (ACPE)-accredited programs were 77.5% in 2024, reflecting a stable trend around 76-78% in recent years. Additionally, candidates must pass the Multistate Pharmacy Jurisprudence Examination (MPJE) or a state-specific exam to demonstrate knowledge of regulations and statutes in the jurisdiction of practice. The MPJE, also from NABP, features 120 questions over 2.5 hours and saw first-time pass rates averaging approximately 78% in 2024, up from 74% in 2023 following exam improvements. In the , registration with the General Pharmaceutical Council (GPhC) is mandatory for legal practice as a pharmacist. This involves completing an accredited (MPharm) degree, a one-year pre-registration period, and passing the GPhC registration assessment, which tests applied knowledge in clinical practice, , and ethics. Overseas-trained pharmacists must meet equivalency criteria, including proficiency and potentially an adaptation period or exam. Beyond initial licensure, pharmacists can pursue in specialties through the Board of Pharmacy Specialties (BPS). For example, the Board Certified Pharmacotherapy Specialist (BCPS) credential requires an active pharmacy license, at least three years of post-licensure practice or a PGY1 residency plus two years of experience, and passing a 175-question exam on principles. Similar processes apply to other BPS-recognized specialties, such as or critical care pharmacy, with over 50,000 pharmacists holding BPS certifications as of 2025. Licensure renewal in the U.S. typically occurs every one to three years, depending on the state, and involves submitting proof of (CE) hours—often 15-45 hours per cycle—payment of fees ranging from $100 to $500, and criminal background checks to ensure ongoing fitness to practice. Jurisprudence updates, such as retaking portions of the MPJE, may be required in some states to address changes in law. International reciprocity poses challenges due to varying standards, limiting direct credential transfer between countries. In the U.S., foreign-educated pharmacists must obtain Foreign Pharmacy Graduate Examination Committee (FPGEC) certification by passing the Foreign Pharmacy Graduate Equivalency Examination (FPGEE), a 200-question test evaluating biomedical, pharmaceutical, social/behavioral, and clinical sciences knowledge, followed by NAPLEX and MPJE. The FPGEE pass rate hovers around 60-70% for first-time takers. Globally, the International Pharmaceutical Federation (FIP) promotes harmonization through frameworks like the Global Competency Framework, aiming to align education and practice standards to facilitate safer cross-border mobility for pharmacists.

Continuing Professional Development

Continuing professional development (CPD) is a mandatory requirement for pharmacists in many jurisdictions to ensure ongoing competency in an evolving healthcare landscape, typically involving 20-40 hours or credits annually through structured activities such as workshops, online modules, and conferences. In the United States, requirements vary by state but generally mandate 15-30 contact hours every one to two years for license renewal, often delivered via accredited continuing pharmacy education (CPE) programs. In , pharmacists must complete at least 40 CPD credits per annual cycle (October 1 to September 30), encompassing a mix of knowledge-based learning and practice application. Similarly, in the , mandatory CPD under revalidation requires pharmacists to complete four CPD entries annually, with at least two planned, each reflecting and learning outcomes. These obligations integrate directly with re-licensure cycles, where failure to meet CPD standards can result in registration suspension or audit escalation by bodies like state boards or the Pharmacy Board of . CPD topics emphasize updates essential to contemporary pharmacy practice, including new drug approvals and therapeutic advancements, for , telepharmacy for remote service delivery, and responses to crises such as pandemics. For instance, programs often cover protocols, in chronic like and , and regulatory changes in controlled substances prescribing. These areas align with evidence-based needs assessments, ensuring pharmacists adapt to innovations like and equity in healthcare access. Pharmacists track CPD via personal portfolios that document activities, reflections, and outcomes, supplemented by digital platforms provided by professional organizations for streamlined logging and compliance verification. In , the Pharmaceutical Society of 's online portal enables real-time entry of CPD activities, while the UK's Royal Pharmaceutical Society offers a MyCPD tool for similar portfolio management. Regulatory bodies conduct periodic audits, such as random reviews of portfolios by the Pharmacy Board of , to confirm adherence and quality of learning application. These systems promote accountability, with non-compliance potentially leading to remediation plans or professional sanctions. Evidence links robust CPD participation to improved patient safety, including reduced medication errors through enhanced clinical decision-making and error prevention strategies. Pharmacist-led educational interventions, a core CPD component, have demonstrated up to a 50% reduction in prescribing and dispensing errors in healthcare settings. Incentives for completing CPD include salary enhancements for those achieving board certifications, which require ongoing CPD for recertification; board-certified pharmacists, such as those with BCPS certification, often earn around 6% more than non-certified peers on average due to recognized expertise. Such motivations, alongside re-licensure imperatives, underscore CPD's role in professional advancement and error mitigation.

Practice Settings

Community and Retail Pharmacy

Community and retail pharmacies serve as the primary point of access for medication dispensing and advice for the general , operating in settings that emphasize and integration with everyday shopping. Pharmacists in these environments handle high-volume dispensing of prescriptions, often processing hundreds daily, while providing over-the-counter (OTC) medication recommendations and conducting basic screenings such as checks to promote early detection of conditions like . These operations ensure safe medication use through clinical reviews, on proper administration, and monitoring for potential interactions, all while maintaining compliance with regulatory standards. Business models in community pharmacy vary significantly between chain and independent operations, influencing daily workflows and service delivery. Chain pharmacies, such as CVS in the or Boots in the , benefit from centralized inventory management, standardized protocols, and extended hours, including 24/7 availability in many locations, which has expanded post-2020 to meet increased demand for accessible care amid the . Independent pharmacies, often owned by individuals or small groups, focus on personalized service and local needs, managing their own inventory and sales of health-related products, though they may face higher operational costs without corporate support. In the U.S., community pharmacists collectively handle approximately 90% of all prescriptions, underscoring their central role in the healthcare system. Beyond dispensing, community pharmacists play a key role in initiatives, enhancing accessibility to preventive services. They administer immunizations, such as flu and vaccines, contributing to higher rates in underserved areas. Programs for involve counseling, recommendations, and follow-up support to improve quit rates. Additionally, medication synchronization services align refill dates for multiple prescriptions, improving patient adherence and reducing the risk of gaps in therapy. Despite these contributions, pharmacists in retail settings face significant challenges, including intense workload pressures from high prescription volumes—averaging 200-300 per day in busy locations—which can lead to burnout and errors if is inadequate. Economic factors, such as declining reimbursements and drug shortages, exacerbate these issues, prompting adaptations like technology integration for efficiency.

Hospital and Clinical Pharmacy

Hospital and clinical pharmacy encompasses the specialized practice of pharmacy within institutional healthcare environments, where pharmacists collaborate directly with interdisciplinary teams to optimize medication therapy for inpatients and outpatients in settings. This field emphasizes -centered care, medication safety, and integration into workflows, distinct from community pharmacy's focus on outpatient dispensing. The expansion of clinical pharmacy roles accelerated in the early through federal funding that supported the growth of faculty and training programs in colleges of pharmacy, enabling pharmacists to transition from primarily distributive roles to active participants in care teams. The 1975 Millis Commission report, "Pharmacists for the Future," further catalyzed this shift by recommending reforms to prepare pharmacists for direct care in hospitals and clinics. In inpatient settings, hospital pharmacists engage in multidisciplinary rounding with physicians, nurses, and other providers to review medication regimens, recommend adjustments, and ensure therapeutic efficacy while minimizing risks. They also oversee the preparation of intravenous (IV) admixtures in centralized pharmacy intravenous admixture services (PIVAS), where sterile reduces contamination risks and ensures accurate dosing for complex therapies like or antibiotics. Additionally, pharmacists lead or support antimicrobial stewardship programs, which promote judicious antibiotic use through prospective audits, education, and de-escalation recommendations to combat resistance and improve outcomes. These efforts have demonstrated significant impact, with clinical pharmacists on rounds reducing preventable adverse events by 66% to 78%. Clinical services in hospital pharmacy include pharmacokinetic dosing consultations, where pharmacists apply principles of drug absorption, distribution, metabolism, and elimination to individualize therapies. For instance, steady-state peak plasma concentration (C_{ss, max}) for repeated intravenous bolus dosing can be calculated using the equation: Css,max=F⋅Dose/Vd1−e−k⋅τC_{ss, max} = \frac{F \cdot Dose / V_d}{1 - e^{-k \cdot \tau}} where FF is bioavailability (1 for IV), DoseDose is the administered dose, VdV_d is the volume of distribution, kk is the elimination rate constant, and τ\tau is the dosing interval; this formula helps achieve therapeutic levels while avoiding toxicity for drugs like vancomycin or aminoglycosides. Pharmacists also conduct patient monitoring, tracking laboratory results, vital signs, and adverse effects to adjust regimens, and provide consults on drug interactions, formulary alternatives, and chronic disease management. In emergency and critical care, hospital pharmacists respond to code situations, such as cardiac arrests, by rapidly preparing and verifying medications from crash carts, ensuring compliance with protocols. They also manage cases, including overdoses and poisonings, by recommending antidotes, decontamination strategies, and supportive care in collaboration with emergency teams. Clinical staff pharmacists often attend all adult code events 24/7 to prevent errors and optimize during high-stress scenarios. Technology plays a pivotal role in hospital pharmacy operations, with electronic health records (EHRs) enabling real-time access to patient data for informed decision-making and seamless communication across teams. Automated dispensing systems, such as cabinets integrated with EHRs, streamline medication retrieval, reduce dispensing errors by minimizing manual handling, and enhance in high-volume settings. These tools allow pharmacists to focus more on clinical interventions rather than routine tasks.

Specialized and Industrial Roles

Industrial pharmacists play a pivotal role in the pharmaceutical sector, focusing on the research, design, development, and testing of new medicines and treatments. They contribute to drug formulation, ensuring and through rigorous processes. In , these professionals collaborate with multidisciplinary teams to advance products from preclinical stages to market readiness. Regulatory affairs pharmacists oversee compliance with global standards, preparing and submitting documentation such as FDA applications to secure approvals for new drugs and devices. They navigate complex legislative requirements to facilitate timely market access while mitigating legal risks. Quality assurance pharmacists ensure manufacturing processes adhere to good manufacturing practices (GMP), conducting audits, validating procedures, and verifying product integrity to prevent contamination or deviations. They work closely with research and development, manufacturing, and regulatory teams to maintain high standards throughout the production lifecycle. Over 20,000 pharmacists are employed in the U.S. pharmaceutical industry, underscoring the scale of these contributions. In academia and research, pharmacists engage in teaching future professionals, often as lecturers or professors in pharmacy schools, where they deliver curricula on therapeutics, , and patient care. They also lead clinical trials, designing protocols, monitoring participant safety, and analyzing data to evaluate drug efficacy and adverse effects. specialists among them monitor post-market drug safety, assessing adverse event reports, identifying signals of harm, and recommending risk mitigation strategies to regulatory bodies. Pharmacists in research increasingly contribute to through , interpreting genomic data to tailor therapies, such as adjusting doses based on genetic variants to optimize outcomes and reduce toxicity. The (ASHP) emphasizes their role in implementing clinical testing as part of medication management. Specialized clinical roles extend pharmacists' expertise into niche areas requiring advanced certifications. In oncology pharmacy, board-certified oncology pharmacists (BCOP) design, implement, and modify pharmacotherapeutic plans for cancer patients, managing complex regimens like chemotherapy and immunotherapies while addressing supportive care needs. Nuclear pharmacists, holding board certification in nuclear pharmacy (BCNP), specialize in procuring, compounding, and dispensing radiopharmaceuticals for diagnostic imaging and therapeutic applications in nuclear medicine. They ensure safe handling of radioactive materials, complying with radiation safety protocols. Veterinary pharmacists, often credentialed through specialized certificate programs, provide pharmaceutical care for animals, compounding species-specific formulations and advising on antimicrobial stewardship to combat resistance in veterinary practice. These certifications, offered by bodies like the Board of Pharmacy Specialties (BPS) and the International Pharmaceutical Federation, validate expertise in these domains. Pharmacists also hold key positions in public health and policy, particularly within agencies like the U.S. (FDA) and the (WHO). At the FDA, they provide regulatory, scientific, and clinical expertise, reviewing drug applications, advising on policy, and ensuring public safety through pharmacovigilance and risk evaluation strategies. The ASHP advocates for pharmacists' integration into initiatives, including disease prevention, programs, and efforts at global, national, and local levels. In WHO roles, they contribute to international , lists, and global networks to address health inequities. The highlights their expanding influence beyond dispensing to policy advocacy and access improvement.

Regulation and Professional Standards

Licensing Requirements

Licensing to practice pharmacy is governed by regulatory authorities that establish and enforce standards to protect , typically at the national or subnational level. In the United States, each of the 50 states, the District of Columbia, and certain territories maintains its own board of pharmacy, which administers licensing under the coordination of the National Association of Boards of Pharmacy (NABP). These boards require applicants to hold a (PharmD) degree from an Accreditation Council for Pharmacy Education (ACPE)-accredited program, complete a specified number of hours—often around 1,500 to 1,740 under a licensed pharmacist's —and pass national examinations. The primary exams include the North American Pharmacist Licensure Examination (NAPLEX), which assesses pharmaceutical knowledge and skills, and the Multistate Pharmacy Jurisprudence Examination (MPJE) for state-specific laws, with fees such as a $100 non-refundable application fee and $520 exam fee for the NAPLEX (total $620) and varying state application costs from $100 to $500. Background checks and application fees are also standard, and foreign-educated pharmacists must obtain Foreign Pharmacy Graduate Equivalency Committee (FPGEC) certification before eligibility. In the , licensing is managed by national pharmacy authorities without a centralized EU board, though Directive 2005/36/EC facilitates automatic mutual recognition of qualifications for pharmacists trained in EU/EEA countries, allowing practice across member states after notification to the host country's authority. Non-EU applicants face country-specific processes, often involving equivalence assessments, language proficiency tests, and adaptation periods or aptitude exams, coordinated through bodies like the Pharmaceutical Group of the (PGEU). Globally, the International Pharmaceutical Federation (FIP) supports harmonized competency frameworks but emphasizes that licensing remains a national responsibility, with processes generally mirroring those in the US and : educational prerequisites, practical training, and competency-based exams. Interstate and international mobility is facilitated through reciprocity mechanisms to address workforce needs. In the , NABP's Electronic Licensure Transfer Program (e-LTP) allows licensed pharmacists in good standing to transfer credentials to additional states by verifying eligibility and passing any required state law exam, promoting portability without re-examination of core competencies. Internationally, mobility is more restricted; for instance, mutual recognition applies only to intra-EU movement, while non-EU pharmacists may need full re-licensing, though FIP advocates for streamlined pathways amid global shortages. As of 2024, the had approximately 376,000 active licensed pharmacists, a figure projected to grow amid ongoing shortages that have prompted initiatives like expanded reciprocity to bolster supply. Enforcement of licensing standards involves ongoing monitoring, inspections of practice sites, and disciplinary proceedings for violations such as improper dispensing, record-keeping errors, or . US state boards investigate complaints, imposing sanctions including reprimands, probation, fines, suspension, or revocation; for example, California's Board of publicly reproves licensees for minor infractions and suspends licenses for serious breaches like fraudulent prescribing. Similar mechanisms exist globally, with national registries conducting audits and revoking licenses for to maintain professional integrity, often in response to workforce pressures that encourage but do not compromise rigorous oversight. Pharmacists are guided by ethical principles that prioritize patient welfare, including maintaining patient confidentiality, obtaining , and avoiding conflicts of interest. In the United States, patient confidentiality is protected under the Health Insurance Portability and Accountability Act (HIPAA) of 1996, which requires pharmacists to safeguard (PHI) and limits disclosures without patient authorization, ensuring privacy in medication counseling and records management. involves providing patients with sufficient information about medications, including risks, benefits, and alternatives, to support autonomous , as outlined in professional guidelines that emphasize transparency in pharmacy practice. To avoid conflicts of interest, pharmacists must disclose any financial or personal incentives that could influence recommendations, such as affiliations with drug manufacturers, and prioritize patient needs over commercial pressures. Legal liabilities for pharmacists encompass and , particularly in cases of dispensing errors or mistakes. occurs when a pharmacist breaches the , such as failing to verify prescriptions or warn about interactions, leading to harm; for instance, courts have held pharmacists accountable in cases where incorrect dosages caused severe adverse events, resulting in settlements or awards for medical expenses and pain. arises from errors, where pharmacists prepare customized medications; deviations in formulation or sterility can lead to infections or overdoses, exposing practitioners to claims under standards, as seen in incidents where contaminated compounds hospitalized . Professional codes of conduct reinforce these ethics, with the American Pharmacists Association (APhA) Code of Ethics, first established in 1852 and revised in 1994, emphasizing principles of beneficence—acting for benefit—and , ensuring equitable access to care while upholding integrity and avoiding discrimination. Internationally, the Fédération Internationale Pharmaceutique (FIP) adopted the Universal Declaration of Ethics for Pharmacists in 1997, which outlines pharmacists' duties to respect , promote rational drug use, and collaborate ethically with healthcare teams, serving as a foundational global standard. Pharmacists frequently encounter ethical dilemmas, such as balancing pressures from payers or employers with adherence to best practices, where pressures to dispense cheaper generics may conflict with recommending more effective therapies tailored to needs. In end-of-life care, dilemmas arise in decisions about dispensing medications for or , requiring pharmacists to navigate autonomy, legal restrictions, and moral concerns like avoiding undue hastening of while alleviating . A notable example of rising litigation involves opioid dispensing, with post-2010 lawsuits against pharmacy chains alleging failure to monitor suspicious prescriptions, contributing to the and resulting in multibillion-dollar settlements for inadequate oversight.

Professional Organizations

Professional organizations play a vital role in supporting pharmacists through advocacy, education, and networking, fostering the profession's growth and influence on healthcare policy worldwide. The International Pharmaceutical Federation (FIP), founded in , serves as the premier global body representing over 5.5 million pharmacists and pharmaceutical scientists across more than 100 countries. FIP advocates for the expansion of pharmacists' , establishes international standards for pharmaceutical education and care, and organizes networking events such as its annual World Congress of Pharmacy and Pharmaceutical Sciences. Membership in FIP provides access to professional development resources, including policy statements and guidelines that influence . At the national level, organizations like the American Pharmacists Association (APhA) and the Royal Pharmaceutical Society (RPS) exemplify dedicated and support structures. APhA, established to advance the pharmacist's role in improving use and patient care, engages in legislative to expand clinical services and provides members with benefits such as access to peer-reviewed journals, certificate training programs, and participation in policy development committees. Similarly, the RPS champions the safe and effective use of medicines in the UK, setting professional standards through competency frameworks and facilitating networking via regional events and online communities, while offering members resources like tools and influence on . Specialty organizations, such as the American College of Clinical Pharmacy (ACCP), focus on advancing clinical pharmacy practice. ACCP promotes research, , and optimal outcomes, offering members certifications, board preparation resources, and access to the journal Pharmacotherapy, alongside advocacy for integrating pharmacists into patient care teams. These groups collectively enable policy influence, such as FIP's contributions to response guidelines, which outlined pharmacists' roles in distribution, administration, and combating to support equitable access. FIP's global impact extends to initiatives like World Pharmacist Day, observed annually on , which highlights pharmacists' contributions to healthcare and encourages worldwide events to raise awareness of their expertise. Through such campaigns, professional organizations not only enhance networking and standard-setting but also amplify pharmacists' voice in addressing challenges.

Global Variations in Practice

North America

In the United States, aspiring pharmacists must complete a (Pharm.D.) degree from a program accredited by the Accreditation Council for Pharmacy Education (ACPE), typically spanning four years following prerequisite undergraduate coursework. Licensure requires passing the North American Pharmacist Licensure Examination (NAPLEX), which assesses competency in practice, and in most states, the Multistate Jurisprudence Examination (MPJE), which covers state-specific laws and regulations. varies by state, but collaborative practice agreements allowing pharmacists to initiate, modify, or manage under protocols with physicians are permitted in all 50 states and the District of Columbia. Although the U.S. projects a 5% growth in pharmacist employment from 2024 to 2034, current personnel shortages persist, particularly in settings where over 80% of directors report shortages of experienced pharmacy technicians. In Canada, the entry-to-practice qualification is the four-year Pharm.D. program offered by accredited universities, preparing graduates for diverse roles in patient care and medication management. The Pharmacy Examining Board of Canada (PEBC) oversees national certification through examinations, including the Evaluating Examination for international graduates and the Qualifying Examination, which tests knowledge and skills for safe practice. Regulation occurs at the provincial level, with each province's college of pharmacists setting standards for licensure, , and , often emphasizing culturally safe care for Indigenous populations through training in and . Bilingual services in English and French are prioritized, particularly in minority language settings, with requirements integrated into licensure pathways for internationally educated pharmacists to ensure equitable access. In , pharmacists typically earn a five-year (Licenciatura en Farmacia) from universities accredited by the Secretaría de Educación Pública (SEP), focusing on pharmaceutical sciences, , and . The Federal Commission for the Protection against Sanitary Risk (COFEPRIS), under the Secretaría de Salud, regulates pharmacy practice, including approval, dispensing standards, and professional oversight to ensure and . Clinical roles for pharmacists are expanding, with increasing involvement in counseling, , and interdisciplinary care in hospitals and community settings, driven by regional efforts to advance in . Across , common trends include greater reliance on to support pharmacists in dispensing and administrative tasks, with programs like those from the Pharmacy Technician Certification Board (PTCB) standardizing technician training and enabling pharmacists to focus on clinical responsibilities. Post-pandemic, telepharmacy has seen significant growth, particularly in the U.S. and , allowing remote verification of prescriptions and consultations to improve access in rural and underserved areas, with the North American market projected to expand at a of over 10% through 2032.

Europe

In Europe, the profession of pharmacy is shaped by a harmonized regulatory framework within the (), primarily through Directive 2005/36/EC, which establishes mutual recognition of professional qualifications for pharmacists across member states. This directive facilitates the free movement of pharmacists by requiring member states to recognize diplomas, certificates, and other evidence of formal qualifications obtained in another country, provided they meet minimum training standards, typically a five-year integrated (MPharm) degree or equivalent. As of 2024, the and associated regions are home to over 400,000 community pharmacists, underscoring the profession's significant scale in supporting systems. Country-specific practices reflect both alignment and national priorities. In , pharmacists must pass the state examination for pharmacists (Apothekerprüfung), a rigorous oral and practical assessment based on the , to obtain approbation and practice independently. The United Kingdom's General Pharmaceutical Council (GPhC) enables qualified pharmacists to become independent prescribers through accredited postgraduate training, allowing them to prescribe medications autonomously within their competence, a role expanded to enhance patient access in . In , holds a prominent focus, with pharmacists actively involved in medication management, rational drug use, and clinical services within hospital settings, often integrating into multidisciplinary teams to optimize therapy. Outside the EU, non-member countries maintain distinct yet compatible systems. requires pharmacists to hold a federal diploma, obtained after completing a five-year master's program followed by a federal examination that tests pharmaceutical knowledge and practical skills. emphasizes integrated care models, where community and hospital pharmacists collaborate closely with primary healthcare teams to provide reviews, adherence support, and chronic disease management, aligning with the country's universal healthcare structure. Emerging trends in European pharmacy include the integration of , with pharmacists increasingly interpreting genetic test results to personalize drug therapy and reduce adverse reactions, supported by guidelines from bodies like the Dutch Pharmacogenetics Working Group adapted across the region. Cross-border mobility is further enabled by the EU's mutual recognition mechanisms, allowing pharmacists to practice temporarily or permanently in other member states with minimal barriers, promoting workforce flexibility amid shortages. Following in 2020, the adjusted its framework by maintaining recognition of pre-2021 EU qualifications for pharmacists but ending automatic mutual recognition, requiring new applicants from the EU to meet domestic standards or undergo equivalence assessments.

Asia and Oceania

In Asia and Oceania, pharmacy practice varies widely, reflecting a blend of advanced regulatory systems, integration of , and efforts to address challenges in both urban and rural settings. Countries like and / feature highly structured education and professional scopes, while and grapple with expanding clinical involvement amid issues like counterfeit drugs. Regional trends emphasize digital integration and to enhance access and quality. Japan maintains one of the world's most rigorous systems, requiring a six-year integrated undergraduate program that combines foundational sciences, clinical training, and practical experience, implemented since 2006 to align with global standards. Graduates must pass a national licensing examination administered by the Ministry of Health, Labour and Welfare to practice. A distinctive aspect is the integration of medicine—traditional Japanese herbal formulations—into the curriculum, with all pharmacy schools incorporating dedicated courses on its principles, prescriptions, and evidence-based applications to support its role in national healthcare. As of 2020, Japan had approximately 322,000 registered pharmacists, supporting a dense network of community and pharmacies that emphasize patient counseling and management. In and , pharmacy education typically involves a four-year (Honours) degree, focusing on pharmaceutical sciences, clinical practice, and interprofessional collaboration, followed by supervised and registration. In , pharmacists register with the Australian Health Practitioner Regulation Agency (AHPRA) and the Pharmacy Board of , ensuring compliance with national standards for safe practice. In Australia, pharmacists pursue diverse career paths, including community and retail pharmacy focused on patient counseling and dispensing; hospital pharmacy involving clinical services and drug management; roles in the pharmaceutical industry such as research and development, regulatory affairs, medical affairs, and sales and marketing; academia and research; consulting in settings like aged care facilities; and positions in government and regulatory agencies. pharmacists register through the Pharmacy Council, which oversees similar competency-based requirements. Both countries grant pharmacists expanded authority to administer vaccines, including , , and certain childhood immunizations for patients aged five and older, after completing accredited training; this scope has broadened access, particularly during campaigns. To address rural pharmacy shortages, promotes telepharmacy services through policy initiatives like those from the Rural Health Alliance, enabling remote verification of prescriptions and counseling via video, though implementation varies by state. India and China offer pharmacy education through diploma and bachelor's programs, with India's (DPharm) lasting two years and (BPharm) four years, emphasizing manufacturing, dispensing, and basic clinical knowledge under the . In China, the BPharm is generally a four-year program, though clinical pharmacy tracks extend to five years, preparing graduates for roles in and settings via the National Medical Licensing Examination. Both nations are expanding pharmacists' clinical roles, such as medication reconciliation and in hospitals, driven by healthcare reforms to improve outcomes in chronic disease management. However, counterfeit drugs pose significant challenges: in India, estimates suggest 12-25% of pharmaceuticals may be falsified, undermining trust and efficacy; in China, substandard or fake medicines have historically caused thousands of deaths annually, prompting stricter systems. Across and , trends include rapid adoption of tools in , with telepharmacy and e-prescribing platforms surging post-COVID-19 to enhance rural access and efficiency in the region. In , harmonization efforts through the ASEAN Pharmaceutical Regulatory Policy aim to align standards for drug registration, , and traditional medicines, facilitating cross-border trade and equitable medicine access among member states.

and Developing Regions

In and other developing regions, pharmacy practice operates amid significant resource constraints, including acute workforce shortages that hinder effective healthcare delivery. faces a pharmacist density of approximately 1 per 10,000 population, far below global averages and contributing to gaps in medication management and services. This scarcity exacerbates challenges in addressing prevalent issues, such as infectious s and , where pharmacists play a in dispensing and counseling. In , the standard pharmacy education program is a five-year (BPharm) degree, overseen by the Pharmaceutical Society of Nigeria (PSN), which serves as the ensuring standards and continuous development for practitioners. Similarly, in , pharmacy training emphasizes management of (NTDs), with district pharmacists trained to handle mass drug administration (MDA) for conditions like and through WHO-supported guidelines. These examples highlight efforts to align with regional burdens, amid ongoing challenges in achieving recommended densities across the continent. Counterfeit and substandard medicines pose another major threat, with up to 18.7% of pharmaceutical samples in failing quality tests, undermining treatment efficacy and . Pharmacists in these settings often detect and report falsified drugs, but training gaps limit their capacity; many programs lack sufficient focus on clinical skills, , and , leading to inconsistent . In , similar issues manifest through supply disruptions, as seen in , where have drastically reduced access to , causing shortages in up to 85% of required pharmaceuticals as of 2017 and straining distribution networks. Recent estimates indicate shortages around 28% as of 2024. counters some challenges with structured residency programs, initiated in the 1990s and now including multiprofessional training in , , and hospital settings to build specialized expertise. Innovations are emerging to address these barriers, particularly through community-based training models that integrate pharmacists into . In , programs supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) have expanded the pharmacy workforce by training over 340,000 health workers, including pharmacists, to manage medications and improve retention in rural areas. WHO-backed lists further empower pharmacists by prioritizing affordable, high-impact s for local procurement and rational use, reducing waste and enhancing access in low-resource contexts. These approaches foster equitable service delivery, though sustained investment is needed to bridge ongoing gaps in and . As of 2025, digital tools like mobile apps for verification are increasingly adopted in regions like to combat counterfeits and improve access.

History of the Profession

Origins and Early Development

The practice of pharmacy originated in ancient civilizations, where the compounding of natural substances for medicinal purposes formed the foundation of early . In , around 2400 BCE, the oldest known prescriptions were inscribed on a Sumerian , detailing remedies derived from plants, minerals, and animal products to treat ailments such as infections and digestive issues. Similarly, ancient Egyptian practitioners documented extensive techniques in the , circa 1500 BCE, which outlines over 700 formulas incorporating , , and minerals for conditions ranging from eye disorders to internal diseases. In , by the 5th century BCE, and his followers advanced these practices by emphasizing rational, empirical preparation of compound medicines, separating pharmaceutical from superstition and integrating it into systematic medical care. During the medieval period, pharmacy evolved significantly in the Islamic world during the (8th-14th centuries), where the first known pharmacies (saydalas) were established in around 754 CE under the . Scholars like Sabur Ibn Sahl compiled the earliest surviving in 850 CE, detailing drug preparations and dosages, while figures such as Al-Razi and Ibn Sina advanced pharmaceutical knowledge through systematic texts on and compounding. Regulations separated from , with ethical standards for practitioners, influencing later European developments through translations and trade. In , pharmacy evolved into a distinct craft through the role of apothecaries, who specialized in preparing and dispensing compounded drugs. By the , apothecaries formed guilds across cities like and to standardize quality, enforce ethical practices, and assert independence from physicians, who focused on diagnosis rather than preparation. A pivotal milestone occurred in 1240 when Frederick II issued an edict in the Kingdom of , mandating the separation of from , regulating the compounding and pricing of medicines, and requiring oversight by university-trained experts—this was the first formal legal framework for the profession in . The , established as a center for higher learning around 1088 with medical studies intensifying by the early , incorporated early instruction in and pharmaceutical preparation as part of its curriculum, influencing the development of systematic training. European colonial expansion in the 16th and 17th centuries transplanted these apothecary traditions to the , where settlers and missionaries established rudimentary pharmacies to compound remedies using imported European ingredients alongside local botanicals. In North American colonies like Jamestown and Plymouth, early practitioners relied on guild-influenced methods brought from and , adapting them to new environments despite limited supplies. In the UK, the Apothecaries Act of marked a significant formalization of training, requiring apprenticeships, examinations in , chemistry, and , and licensing to practice, thereby elevating the profession's standards. Gender barriers limited women's participation in pharmacy until the late , with formal exclusion from guilds and training programs in reinforcing male dominance. In the UK, these restrictions began to lift in the 1870s following advocacy and legal reforms; the Pharmaceutical Society admitted its first female members in 1879, and Fanny Deacon became the inaugural registered female pharmacist in 1870, paving the way for broader access to education and practice.

Modern Evolution and Key Milestones

The professionalization of pharmacy accelerated in the 19th and early 20th centuries with the establishment of formal educational standards and regulatory frameworks to ensure drug safety and practitioner competence. In the United States, the of 1906 marked a pivotal milestone by prohibiting the interstate commerce of misbranded or adulterated drugs, thereby elevating the pharmacist's role in verifying product integrity and advising on safe use. This legislation laid the groundwork for greater oversight, prompting the standardization of pharmacy education; by the mid-20th century, programs became the norm in many institutions, influenced by surveys like the 1948 Pharmaceutical Survey that recommended curriculum reforms to emphasize pharmaceutical sciences. Post-World War II developments further transformed the profession, shifting it toward patient-centered care. The (ASHP) was founded in 1942 to advance practices, fostering specialized training and residency programs that professionalized inpatient services. The Durham-Humphrey Amendment of 1951 to the Federal Food, Drug, and Cosmetic Act distinguished prescription (Rx) from over-the-counter (OTC) medications, requiring pharmacist involvement for legend drugs and reinforcing their gatekeeping role in distribution. By the 1960s, emerged as a distinct practice model, exemplified by initiatives like the , San Francisco's Ninth-Floor Pharmacy Project in 1966, which integrated pharmacists into patient care teams for drug therapy monitoring and optimization. In the 2020s, pharmacists have pushed for expanded provider status in the U.S., with legislative efforts in over 20 states granting authority for services like vaccine administration and chronic disease management, accelerated by demonstrated value during crises. The highlighted pharmacists' frontline roles in drives, testing, and , administering over 100 million doses in the U.S. by mid-2021 and prompting temporary waivers for remote services, with cumulative contributions exceeding 300 million doses throughout the . Technological advancements, including for automated dispensing and error detection, have streamlined operations while allowing more time for clinical interventions, with tools now integrated into major pharmacy systems for on drug interactions. Telepharmacy surged post-2020, with federal and state policies enabling remote verification in underserved areas, expanding access amid workforce shortages. Globally, the International Pharmaceutical Federation (FIP) has played a central role in milestones through collaborations with the (WHO), including joint development of standards and responses to since the 1990s. By 2025, women comprise approximately 65% of the global pharmacy , reflecting a sustained trend toward equity driven by educational access and professional advocacy efforts.

Notable Pharmacists

Historical Figures

, born Bombastus von Hohenheim in 1493 and active until 1541, revolutionized by introducing chemical substances such as minerals and metals into medical practice, challenging the dominance of herbal remedies derived from ancient traditions. He is widely regarded as the father of for emphasizing the importance of dosage in therapeutics, famously stating that "," which laid foundational principles for understanding drug safety and efficacy. advocated for empirical observation over dogmatic authority, promoting the use of chemicals like mercury for treating , thereby bridging and modern . Galen of , active around 200 AD, made enduring contributions to the development of pharmacopeias through his extensive writings on the properties and of simple medicines, compiling knowledge from earlier sources like Dioscorides into systematic treatises. His work, including the 11-volume On the Mixtures and Properties of Simple Drugs, standardized the preparation and of medicinal substances, influencing pharmaceutical practices for over a millennium by establishing guidelines for drug mixtures and dosages based on humoral theory. This foundational pharmacopeia helped formalize as a distinct , separate from mere . In medieval Europe, the profession of began to separate from , a pivotal shift formalized in 1240 by Frederick II, who issued an edict regulating pharmacists as independent practitioners with specific training and oversight, prohibiting physicians from dispensing drugs. This separation was further advocated in the American context by John Morgan, a physician and pharmacist who, in his 1765 discourse, argued for distinct roles to ensure purity and of medicines, influencing the establishment of as a specialized field. Such addressed risks of adulteration and incompetence, promoting professional autonomy. Early 19th-century pharmacists advanced research in , naturally occurring compounds with potent physiological effects, beginning with Friedrich Sertürner's isolation of from in 1804, which demonstrated pharmacy's role in purifying active principles for safer, more precise dosing. German pharmacist Carl Friedrich Wilhelm Meissner coined the term "alkaloid" in 1818 to describe these alkaline plant bases, while Pierre Joseph Pelletier and Joseph Bienaimé Caventou isolated in 1820, enabling standardized antimalarial treatments and highlighting pharmacists' contributions to chemical analysis and . This era marked pharmacy's transition from empirical compounding to scientific isolation, with apothecaries leading efforts to extract pure substances like and . The establishment of the United States Pharmacopeia (USP) in 1820, convened by 11 physicians in Washington, D.C., represented a milestone in standardization, compiling the first national compendium of drug formulas, strengths, and preparation methods to combat variability in imported and domestic medicines. Charles Rice (1841–1905), a prominent American pharmacist and hospital administrator, chaired three USP revisions (1880, 1882, and 1890), refining standards for purity and nomenclature while serving as associate editor of pharmaceutical journals, thereby elevating pharmacy's role in public health. Elizabeth Gooking Greenleaf (ca. 1681–?), operating in colonial , holds the distinction as the first documented female pharmacist in the United States, opening an shop in 1727 where she compounded and dispensed remedies, navigating gender barriers in a male-dominated trade. (1813–1865), the first African American to earn a abroad and operate a in starting in the 1840s, pioneered access to quality medicines for Black communities, conducting early research on opium's effects and advocating against racial in therapeutics. These figures exemplified 's evolving inclusivity amid broader professional foundations laid in antiquity and the .

Contemporary Contributors

Contemporary pharmacists have made significant strides in advancing the profession through innovative research, policy advocacy, and public health initiatives. Lucinda L. Maine, PhD, RPh, a pioneering leader in pharmacy education and policy, served as Executive Vice President and CEO of the American Association of Colleges of Pharmacy (AACP) from 2002 to 2022, where she advocated for enhanced pharmacy curricula and interprofessional collaboration to improve patient care outcomes. Her earlier role as Senior Vice President for Policy, Planning, and Communications at the American Pharmacists Association (APhA) further solidified her influence on national pharmacy policy, including efforts to expand pharmacists' . Maine's contributions earned her the Remington Honor Medal, pharmacy's highest award, recognizing her lifelong dedication to elevating the profession's role in healthcare. In pharmacogenomics, Mary V. Relling, PharmD, has been a trailblazer, co-founding the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009, which develops evidence-based guidelines for translating genetic test results into personalized drug dosing recommendations. Her work at has focused on reducing adverse drug reactions in pediatric patients through genomic testing, influencing global standards for over 34 genes and 164 drugs. Relling's research emphasizes practical implementation, such as routine screening for variants to prevent from anti-leukemic agents. Global health efforts highlight pharmacists' advisory roles with organizations like the (WHO). For instance, pharmacists contribute to WHO/Europe initiatives by expanding responsibilities in medication management and public health surveillance, advising on antimicrobial stewardship and chronic disease prevention across member states. In , community pharmacists have advanced management through the Pharmacist Initiated Management of Antiretroviral Treatment (PIMART) program, enabling trained professionals to initiate and monitor first-line therapies, a landmark expansion upheld by the Supreme Court of Appeal in 2025 to improve access in underserved areas. Recent impacts include pharmacists' pivotal roles in addressing the opioid crisis and promoting vaccine equity. In opioid management, pharmacists lead stewardship efforts, such as dispensing for overdose reversal and conducting medication reviews to mitigate misuse risks, contributing to a reduction in opioid-related harms through and prescriber collaboration. During the , pharmacists facilitated equitable distribution of mRNA vaccines via the Federal Retail Pharmacy Program (FRPP), administering up to 56.8% of doses for adolescents and supporting access in underserved communities to bridge vaccination gaps. This involvement extended to over 350 million clinical interventions, enhancing and . Diversity in pharmacy leadership has progressed notably by 2025, with women comprising 68.1% of the U.S. pharmacist workforce and holding 67.6% of management positions, reflecting a shift toward greater gender equity in decision-making roles. Representation of minorities has also increased, with non-white pharmacists comprising 21.1% of the actively practicing workforce as of 2024, fostering inclusive leadership that addresses health disparities in global and domestic contexts. With increasing representation of women in leadership roles across national pharmacy associations, their growing influence in shaping policy and innovation is underscored.

References

  1. https://www.bls.gov/ooh/healthcare/pharmacists.htm
  2. https://www.who.int/europe/news-room/feature-stories/item/advancing-the-role-of-pharmacists-to-meet-changing-patient-and-health-system-needs
  3. https://psnet.ahrq.gov/primer/pharmacists-role-medication-safety
  4. https://apps.oregon.gov/DAS/Classification-Compensation/JobProfile/Title/Pharmacist/JobProfileCode/6260/Category/HumanServicesandMedical
  5. https://www.deadiversion.usdoj.gov/GDP/%2528DEA-DC-046R1%2529%2528EO-DEA154R1%2529_Pharmacist%2527s_Manual_DEA.pdf
  6. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding
  7. https://www.ncbi.nlm.nih.gov/books/NBK562881/
  8. https://www.ashp.org/pharmacy-practice/resource-centers/compounding
  9. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  10. https://publications.ashp.org/previewpdf/book/9781585284993/chapter9.xml?pdfJsInlineViewToken=28782929&inlineView=true
  11. https://pmc.ncbi.nlm.nih.gov/articles/PMC7882713/
  12. https://www.msh.org/wp-content/uploads/2013/04/mds3-ch23-inventorymgmt-mar2012.pdf
  13. https://www.onetonline.org/link/summary/29-1051.00
  14. https://www.amcp.org/about/managed-care-pharmacy/what-do-managed-care-pharmacists-do
  15. https://www.aacp.org/article/aacp-highlights-pharmacists-vital-role-guiding-safe-use-otc-medicines
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC6861682/
  17. https://www.ashp.org/-/media/assets/drug-shortages/docs/drug-resources-understanding-managing-drug-product-shortages.pdf
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC8250559/
  19. https://www.sciencedirect.com/science/article/pii/S1551741125004681
  20. https://www.ncsl.org/health/pharmacists-and-pharmacy-technicians
  21. https://ncpa.org/sites/default/files/2022-03/scope-of-practice-legislation.pdf
  22. https://ebusiness.pharmacist.com/PRODUCTFILES/363513345/POCT_CH01.pdf
  23. https://pmc.ncbi.nlm.nih.gov/articles/PMC6789879/
  24. https://www.safemedication.com/pharmacist-insights/2023/10/13/the-evolution-of-the-pharmacist
  25. https://www.drugs.com/insights/evolution-pharmacist-3575659/
  26. https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.2047
  27. https://www.cdc.gov/cardiovascular-resources/media/cpa-team-based-care.pdf
  28. https://www.cato.org/briefing-paper/let-pharmacists-prescribe
  29. https://surescripts.com/insights/more-pharmacists-are-prescribing
  30. https://www.pharmacytimes.com/view/apha-2025-pharmacists-can-prescribe-contraceptives-in-30-states-and-the-district-of-columbia
  31. https://www.researchgate.net/publication/274993400_A_brief_history_of_pharmacist_prescribing_in_the_UK
  32. https://www.ama-assn.org/practice-management/scope-practice/physicians-congress-don-t-expand-pharmacists-scope-practice
  33. https://pubmed.ncbi.nlm.nih.gov/33359117/
  34. https://www.pharmacytimes.com/view/full-scope-of-pharmacy-practice-reinventing-the-future-and-overcoming-barriers
  35. https://www.ashp.org/-/media/assets/policy-guidelines/docs/guidelines/pharmacist-conducted-patient-education-counseling.ashx
  36. https://www.uspharmacist.com/article/obra-90-at-sweet-sixteen-a-retrospective-review
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC6590951/
  38. https://www.pharmacytimes.com/view/how-multi-lingual-labels-and-education-can-help-independent-pharmacies-better-serve-patients
  39. https://www.merckmanuals.com/professional/geriatrics/providing-care-to-older-adults/pharmacists-and-older-adults
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC2769842/
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC4771087/
  42. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/409914
  43. https://www.pharmacytimes.com/view/preventing-adverse-drug-events-a-call-to-action-for-pharmacists
  44. https://www.aacp.org/resource/pharmd-program-structures
  45. https://www.sciencedirect.com/science/article/abs/pii/S1878331712000952
  46. https://euc.ac.cy/en/programs/bachelor-pharmacy/
  47. https://pharmacy.tamu.edu/pharmd/apply.html
  48. https://www.hunter.cuny.edu/students/opportunities/pre-professional-programs/pre-health/course-requirements/pharmacy-school/
  49. https://pharmacy.cuanschutz.edu/degreesandprograms/pharmd/curriculum
  50. https://catalog.roosevelt.edu/graduate/courses/phar/
  51. https://www.ncbi.nlm.nih.gov/books/NBK554498/
  52. https://www.acpe-accredit.org/pdf/ACPEStandards2025.pdf
  53. https://www.ajpe.org/article/S0002-9459%2824%2910628-6/fulltext
  54. https://www.umt.edu/pharmacy-practice/current-students/experiential-program-information.php
  55. https://nabp.pharmacy/wp-content/uploads/NAPLEX-Pass-Rates.pdf
  56. https://nabp.pharmacy/programs/examinations/mpje/
  57. https://nabp.pharmacy/news/blog/the-mpje-pass-rate-improvements/
  58. https://www.pharmacyregulation.org/pharmacists/registering-pharmacist
  59. https://bpsweb.org/pharmacotherapy/
  60. https://bpsweb.org/
  61. https://nabp.pharmacy/programs/cpe-monitor/
  62. https://nabp.pharmacy/programs/foreign-pharmacy/fpgee/
  63. https://trchealthcare.com/pharmacist-ce-requirements-by-state/
  64. https://www.acp.edu.au/education/cpd/cpd-requirements/
  65. https://www.pharmacyregulation.org/pharmacists/revalidation-renewal/revalidation-resources
  66. https://www.pharmacyboard.gov.au/Codes-Guidelines/FAQ/CPD-FAQ.aspx
  67. https://www.fip.org/files/fip/PharmacyEducation/CPD_CE_report/FIP_2014_Global_Report_CPD_CE_online_version.pdf
  68. https://www.pharmacytimes.org/pages/topics
  69. https://www.ashp.org/professional-development/ashp-podcasts/hot-topics-in-pharmacy-practice
  70. https://www.medscape.org/public/pharmcestaterequirements
  71. https://www.acpe-accredit.org/continuing-professional-development/
  72. https://www.psa.org.au/cpd/about-cpd/
  73. https://www.psa.org.au/cpd/looking-for-help-to-access-your-online-membership-portal-features/
  74. https://www.pharmacyboard.gov.au/documents/default.aspx?record=WD15%252F19249&dbid=AP&chksum=6BE%252FhTsOAkCXQSx58VB4Xw%253D%253D
  75. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0253588
  76. https://www.sciencedirect.com/science/article/pii/S1319016422001542
  77. https://www.payscale.com/research/US/Certification=Board_Certified_Pharmacotherapy_Specialist_(BCPS)/Salary
  78. https://bpsweb.org/pharmacists/
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC5909876/
  80. https://pubmed.ncbi.nlm.nih.gov/39143725/
  81. https://psnet.ahrq.gov/perspective/role-community-pharmacists-patient-safety
  82. https://www.cvshealth.com/content/dam/enterprise/cvs-enterprise/pdfs/2024/CVSHealth-Rx-Report-Winter-2024.pdf
  83. https://accessiblemeds.org/resources/reports/2023-savings-report-2/
  84. https://pmc.ncbi.nlm.nih.gov/articles/PMC7523559/
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC12346477/
  86. https://pmc.ncbi.nlm.nih.gov/articles/PMC6631564/
  87. https://www.wolterskluwer.com/en/expert-insights/four-challenges-to-creating-a-future-ready-pharmacy
  88. https://pmc.ncbi.nlm.nih.gov/articles/PMC4821736/
  89. https://pmc.ncbi.nlm.nih.gov/articles/PMC10885495/
  90. https://www.pharmacytimes.com/view/antimicrobial-stewardship-a-primer-for-hospital-pharmacists
  91. https://journals.lww.com/md-journal/fulltext/2017/08250/the_cost_saving_effect_and_prevention_of.40.aspx
  92. https://www.ncbi.nlm.nih.gov/books/NBK553132/
  93. https://www.ashp.org/-/media/assets/policy-guidelines/docs/statements/pharmacists-role-clinical-pharmacokinetic-monitoring.pdf
  94. https://www.ashp.org/-/media/assets/policy-guidelines/docs/guidelines/emergency-medicine-pharmacist-services.ashx
  95. https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.2062
  96. https://www.pdrx.com/articles/why-automated-dispensing-systems-are-a-game-changer
  97. https://www.rpharms.com/resources/careers-information/career-options-in-pharmacy/industrial-pharmacy
  98. https://pharmacy.uconn.edu/100-careers-in-pharmacy/
  99. https://graduate.northeastern.edu/knowledge-hub/working-in-regulatory-affairs-careers-and-trends/
  100. https://www.getreskilled.com/quality-assurance-vs-regulatory-affairs/
  101. https://www.industrypharmacist.org/resources/58ec44a30ab340eda75f17cf2a44de00.pdf
  102. https://pharmacyforme.org/2021/06/24/over-100-pharmacy-career-pathways
  103. https://medicalaffairsspecialist.org/blog/pharmacovigilance-career-guide
  104. https://www.ashp.org/-/media/assets/policy-guidelines/docs/statements/pharmacists-role-clinical-pharmacogenomics.ashx
  105. https://ascopubs.org/doi/10.1200/OP.23.00216
  106. https://bpsweb.org/oncology-pharmacy/
  107. https://bpsweb.org/nuclear-pharmacy/
  108. https://www.powerpak.com/vet
  109. https://bpts.org/credentials/assessment-based-certificates/veterinary-pharmacy/
  110. https://www.fda.gov/about-fda/career-descriptions/pharmacist-positions-fda
  111. https://www.fda.gov/about-fda/jobs-center-drug-evaluation-and-research-cder/pharmacist-careers-cder
  112. https://www.ashp.org/-/media/assets/policy-guidelines/docs/statements/pharmacists-role-public-health.pdf
  113. https://www.apha.org/policy-and-advocacy/public-health-policy-briefs/policy-database/2014/07/07/13/05/the-role-of-the-pharmacist-in-public-health
  114. https://nabp.pharmacy/programs/licensure/
  115. https://www.harborcompliance.com/pharmacist-license
  116. https://nabp.pharmacy/programs/examinations/naplex/
  117. https://nabp.pharmacy/programs/foreign-pharmacy/
  118. https://epheu.eu/free-circulation-of-pharmacists-pharmacists-from-ohter-countries/
  119. https://www.pgeu.eu/professional-practice/
  120. https://www.fip.org/files/content/publications/2025/FINAL_VF-CH2A_Global_pharmacy_workforce_review.pdf
  121. https://nabp.pharmacy/programs/licensure/licensure-transfer/
  122. https://www.fip.org/file/6352
  123. https://nabp.pharmacy/wp-content/uploads/2024/09/American-Journal-of-Pharmaceutical-Education-Article.pdf
  124. https://www.pharmacy.ca.gov/enforcement/discipline.shtml
  125. https://nabp.pharmacy/wp-content/uploads/2023/11/Report-of-the-Task-Force-on-Unprofessional-Conduct-and-Disciplinary-Actions.pdf
  126. https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html
  127. https://ocpinfo.com/ocp-resources/5-things-pharmacy-professionals-should-know-about-informed-consent/
  128. https://ocpinfo.com/ocp-resources/close-up-on-complaints-avoiding-actual-or-percieved-conflict-of-interest-in-business-dealings/
  129. https://www.uspharmacist.com/article/medication-errors-and-liability-issues
  130. https://www.hpso.com/Resources/Legal-and-Ethical-Issues/Alleged-Compounding-Error-Results-in-Patient
  131. https://www.pharmacist.com/Code-of-Ethics
  132. https://www.fip.org/file/1586
  133. https://pmc.ncbi.nlm.nih.gov/articles/PMC5840248/
  134. https://pubmed.ncbi.nlm.nih.gov/12577931/
  135. https://pmc.ncbi.nlm.nih.gov/articles/PMC10713840/
  136. https://www.fip.org/
  137. https://www.pharmacist.com/
  138. https://www.rpharms.com/
  139. https://www.accp.com/
  140. https://www.fip.org/public-health-emergencies
  141. https://www.fip.org/world-pharmacists-day
  142. https://www.pharmacist.com/Blogs/CEO-Blog/collaborative-practice-now-allowed-in-all-50-states
  143. https://www.uspharmacist.com/article/personnel-shortages-continue-to-plague-hospital-pharmacies
  144. https://pebc.ca/
  145. https://www.bcpharmacists.org/indigenous-cultural-safety-cultural-humility-and-anti-racism-education-pharmacy-professionals
  146. https://www.pharmacistsgatewaycanada.ca/before-you-start/language-requirements/
  147. https://globalregulatorypartners.com/countries/mexico-cofepris/
  148. https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1854
  149. https://ptcb.org/
  150. https://www.fortunebusinessinsights.com/remote-dispensing-telepharmacy-market-113543
  151. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=LEGISSUM%253Al23020b
  152. https://single-market-economy.ec.europa.eu/single-market/services/free-movement-professionals/recognition-professional-qualifications-practice_en
  153. https://www.pgeu.eu/wp-content/uploads/2024/11/PGEU-position-on-Pharmacists-Workforce-Shortages.pdf
  154. https://www.abda.de/en/working-in-germany/recognition-of-degrees-in-pharmacy/working-as-a-foreign-pharmacist-in-germany/
  155. https://www.pharmacyregulation.org/pharmacists/changes-registration/becoming-independent-prescriber
  156. https://www.mdpi.com/1660-4601/19/21/14522
  157. https://www.unil.ch/fbm/en/home/menuinst/formation/sciences-pharmaceutiques.html
  158. https://pmc.ncbi.nlm.nih.gov/articles/PMC12481936/
  159. https://www.nature.com/articles/s41431-025-01950-6
  160. https://www.pharmacyregulation.org/pharmacists/registering-pharmacist/eea-qualified-pharmacist-registration/brexit-related-faqs
  161. https://www.psa.org.au/career-and-support/pharmacy-as-a-career/
  162. https://www.fip.org/file/6004
  163. https://www.researchgate.net/publication/274117320_Pharmacy_education_in_Nigeria_The_journey_so_far
  164. https://adphealth.org/upload/resource/PATH-Pharmacists.pdf
  165. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2696509
  166. https://accpjournals.onlinelibrary.wiley.com/doi/abs/10.1002/jac5.1297
  167. https://www.internationalhealthpolicies.org/featured-article/the-often-lethal-side-effects-of-sanctions-on-pharmaceutical-systems/
  168. https://www.convite.org/
  169. http://educa.fcc.org.br/pdf/riesup/v10/en_2446-9424-riesup-10-e024023.pdf
  170. https://www.hiv.gov/federal-response/pepfar-global-aids/pepfar
  171. https://human-resources-health.biomedcentral.com/articles/10.1186/1478-4491-7-54
  172. https://www.who.int/news/item/16-09-2025-who-launches-new-initiative-to-strengthen-pharmaceutical-systems-in-africa
  173. https://www.ttuhsc.edu/pharmacy/museum/pharmacy.history.aspx
  174. https://pmc.ncbi.nlm.nih.gov/articles/PMC8459052/
  175. https://www.ishim.net/ishimj/3/03.pdf
  176. https://www.ncbi.nlm.nih.gov/books/NBK606146/
  177. https://www.jstor.org/stable/1837535
  178. https://www.unibo.it/en/university/who-we-are/our-history
  179. https://www.rpharms.com/about-us/museum/online-exhibitions/celebrating-women-in-pharmacy/women-pharmacists-in-the-19th-century
  180. https://www.fda.gov/about-fda/fda-history/milestones-us-food-and-drug-law
  181. https://www.pharmacypracticenews.com/Clinical/Article/10-24/A-History-of-Pharmacy-as-a-Profession/75032
  182. https://www.fda.gov/media/109482/download
  183. https://www.researchgate.net/publication/390098182_2020_and_the_Pharmacy_Response_to_COVID-19_Resilience_Innovation_and_Transformation_in_a_Global_Crisis
  184. https://ncpa.org/newsroom/news-releases/2021/07/16/pharmacies-deliver-100-million-doses-covid-19-vaccines
  185. https://www.fip.org/files/content/publications/2025/FINAL_VF-CH8_Pharmacys_role_in_the_digital_transformation_of_health.pdf
  186. https://www.uspharmacist.com/article/the-evolving-telepharmacy-dispensing-landscape
  187. https://www.the-pda.org/wp-content/uploads/FIP-evidence-of-impact-around-the-world-report.pdf
  188. https://pmc.ncbi.nlm.nih.gov/articles/PMC7920879/
  189. https://carrington.edu/blog/a-historical-overview-of-pharmacology/
  190. https://library.uab.edu/locations/reynolds/collections/medical-greats/paracelsus
  191. https://pmc.ncbi.nlm.nih.gov/articles/PMC5723202/
  192. https://www.academia.edu/34230617/Galens_Pharmacological_Concepts_and_Terminology_in_Simon_of_Genoas_Clavis_sanationis
  193. https://www.neomed.edu/news/vitals-scott-knoer-on-pharmacists-and-advocacy/
  194. https://www.govinfo.gov/content/pkg/CRECB-1999-pt4/html/CRECB-1999-pt4-Pg5388-2.htm
  195. https://pubmed.ncbi.nlm.nih.gov/27984164/
  196. https://digirepo.nlm.nih.gov/ext/kirtasbse/9316547/PDF/9316547.pdf
  197. https://pharmacy.musc.edu/resources/news/2021/09/women-pharmacist-day
  198. https://chicago.medicine.uic.edu/medicine/about-us/diversity-inclusion/black-history-profile/james-mccune-smith/
  199. https://www.aacp.org/article/lucinda-l-maine-phd-rph
  200. https://www.pharmacy.umn.edu/lucinda-maine
  201. https://www.aacp.org/article/lucinda-maine-receives-remington-honor-medal-highest-honor-pharmacy
  202. https://news.ashp.org/news/feature-stories/2023/04/03/pharmacists-at-the-helm-of-pharmacogenomics-efforts
  203. https://www.researchgate.net/profile/Mary-Relling
  204. https://jppt.kglmeridian.com/fileasset/jppt/2011_Dr_Mary_Relling.pdf
  205. https://iol.co.za/lifestyle/health/2025-10-13-supreme-court-backs-pharmacist-led-hiv-treatment-initiative-in-landmark-ruling/
  206. https://pmc.ncbi.nlm.nih.gov/articles/PMC9805704/
  207. https://www.japha.org/article/S1544-3191%2824%2900336-4/fulltext
  208. https://pmc.ncbi.nlm.nih.gov/articles/PMC9387064/
  209. https://www.aacp.org/sites/default/files/2025-06/2024-npws-executive-summary-5.27.25.pdf
  210. https://www.pharmacytimes.com/view/gender-gap-still-exists-in-pharmacist-leadership
Add your contribution
Related Hubs
User Avatar
No comments yet.